{"artifact":{"id":"open_question-debate-neurodegeneration-4e947085","artifact_type":"open_question","entity_ids":"[\"neurodegeneration\"]","title":"Do protein aggregates in Alzheimer's and Parkinson's disease physically overwhelm microglial phagocytic clearance capacity regardless of receptor activation status, making GPR32 agonism insufficient a","quality_score":0.75,"created_by":"open_question_miner_debates","provenance_chain":"[]","content_hash":"af2132fdffdc9fed82968af9c08949f65f4ef475a6fa17fe033806acf1d13e67","metadata":{"status":"open","_origin":{"url":null,"type":"internal","tracked_at":"2026-04-28T06:05:59.038516"},"field_tag":"neurodegeneration","source_id":"sess_SDA-2026-04-01-gap-014","source_kind":"debate_session","question_hash":"4e94708589b82372","question_text":"Do protein aggregates in Alzheimer's and Parkinson's disease physically overwhelm microglial phagocytic clearance capacity regardless of receptor activation status, making GPR32 agonism insufficient as monotherapy?","importance_elo":1500,"_schema_version":1,"evidence_summary":"Mined from debate session sess_SDA-2026-04-01-gap-014 (supporting_persona=skeptic)","supporting_persona":"skeptic","tractability_score":0.7,"verbatim_quote_offset":-1,"potential_impact_score":0.8,"is_answerable_in_principle":true},"created_at":"2026-04-27T23:05:59.038591-07:00","updated_at":"2026-04-27T23:05:59.038591-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"4b9300c2-01e5-4237-b64e-b9a6364e2231","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"open_question_miner_debates"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[{"source_artifact_id":"bench_ad_protein_aggregation_propensity_v1","link_type":"related","strength":0.75,"evidence":"AD Protein Aggregation Propensity benchmark seeded to evaluate hypotheses/gaps related to open_question-debate-neurodegeneration-4e947085 (forge:benchmark_seed_2026-04-28)."}],"current_artifact_id":"open_question-debate-neurodegeneration-4e947085","is_canonical":true,"supersede_chain":["open_question-debate-neurodegeneration-4e947085"]}